IP 53.75 International Paper Company $IP Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
IP 53.75 International Paper Company $IP Hit a 52 week high of 53.83 Currently at 53.75 +0.09 +0.17% With a day low of 53.60 and a total volume of 125,599.

IP International Paper Company Recent Headline News

International Paper Set to Possibly Pullback After Yesterday's Rally of 1.50%
Comtex SmarTrend(R) - Mon Nov 10, 4:30PM CST
International Paper (NYSE:IP) traded in a range yesterday that spanned from a low of $52.65 to a high of $53.67. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $52.98 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IP: 53.60 (-0.06)

SmarTrend Watching for Potential Pullback in Shares of International Paper After 1.50% Gain
Comtex SmarTrend(R) - Mon Nov 10, 4:30PM CST
International Paper (NYSE:IP) traded in a range yesterday that spanned from a low of $52.65 to a high of $53.67. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $52.98 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IP: 53.60 (-0.06)

Goldman ups price targets for containerboard names to reflect MLP premium
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:44AM CST

RKT: 56.00 (-0.09), IP: 53.60 (-0.06), PKG: 73.15 (-0.57)

Pity The Hedge Fund Manager
George Acs - at Seeking Alpha - Sat Nov 08, 12:13PM CST

CY: 10.18 (+0.02), EBAY: 54.13 (+0.24), MAT: 30.82 (-0.68), ANF: 28.90 (+0.21), IP: 53.60 (-0.06), MOS: 44.21 (+0.10), SBGI: 27.24 (+0.39), TWTR: 38.89 (-0.70), INTC: 33.39 (+0.13)

International Paper Announces Time Change for CEO to Speak at Vertical Research Partners Annual Paper and Packaging Conference on November 19, 2014
PR Newswire - Thu Nov 06, 4:50PM CST
International Paper (NYSE: IP) Chief Executive Officer Mark S. Sutton will speak at the Vertical Research Partners Annual Paper and Packaging Conference on November 19, 2014, in New York City. The presentation is now scheduled to begin at 12:50pm EST, a half hour later than previously announced, followed by a question and answer session. All interested parties are invited to view the presentation and/or listen to the webcast live via International Paper's Internet site http://www.internationalpaper.com by clicking on the "Investors" tab and then clicking on the "Webcasts & Presentations" link. A replay of the webcast will be available on the website approximately three hours after the presentation.
IP: 53.60 (-0.06)

International Paper Hits 52-Week High on Q3 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:25PM CST
Shares of International Paper Company (IP) hit a 52-week high of $53.14 on Nov 4, 2014. The stock closed the session at $52.60, which reflects a decent year-to-date return of 11.7%.
MWV: 44.28 (-0.43), IP: 53.60 (-0.06), FBR: 12.21 (+0.16), MERC: 13.39 (-0.01)

Company News for November 05, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 9:10AM CST
Companies in the News are: ADM,ICE,IP,AFSI
ADM: 51.13 (+0.36), AFSI: 50.61 (+0.07), IP: 53.60 (-0.06), ICE: 220.93 (+1.60)

International Paper (IP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Tue Nov 04, 6:24PM CST
The following International Paper (IP) conference call took place on November 4, 2014, 10:00 AM ET. This is a transcript of that earnings call:
IP: 53.60 (-0.06)

After Yesterday's Rally of 3.91% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 04, 4:32PM CST
International Paper (NYSE:IP) traded in a range yesterday that spanned from a low of $50.78 to a high of $53.14. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high of $51.10 on volume of 5.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IP: 53.60 (-0.06)

International Paper Set to Possibly Pullback After Yesterday's Rally of 3.91%
Comtex SmarTrend(R) - Tue Nov 04, 4:31PM CST
International Paper (NYSE:IP) traded in a range yesterday that spanned from a low of $50.78 to a high of $53.14. Yesterday, the shares gained 3.9%, which took the trading range above the 3-day high of $51.10 on volume of 5.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IP: 53.60 (-0.06)

International Paper's (IP) CEO Mark Sutton on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 3:10PM CST

IP: 53.60 (-0.06)

International Paper Beats on Q3 Earnings, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:00PM CST
International Paper Company (IP) reported operating earnings (excluding one-time items) of $409 million or 95 cents per share for the third quarter of 2014 compared with $455 million or $1.01 per share in the year-ago quarter.
MWV: 44.28 (-0.43), IP: 53.60 (-0.06), FBR: 12.21 (+0.16), MERC: 13.39 (-0.01)

International Paper gains after Q3 beat; Printing Papers stands out
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 11:15AM CST

IP: 53.60 (-0.06)

International Paper beats Street 3Q forecasts
Automated Insights - Tue Nov 04, 6:36AM CST
MEMPHIS, Tenn. (AP) _ International Paper Co. (IP) on Tuesday reported third-quarter earnings of $355 million.
IP: 53.60 (-0.06)

International Paper beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:09AM CST

IP: 53.60 (-0.06)

International Paper Releases Third Quarter Earnings
PR Newswire - Tue Nov 04, 6:00AM CST
International Paper (NYSE: IP) today reported third quarter 2014 net earnings attributable to common shareholders totaling $355 million ($0.83 per share) compared with net earnings of $161 million ($0.37 per share) in the second quarter of 2014 and net earnings of $382 million ($0.85 per share) in the third quarter of 2013. Amounts in all periods include the impact of special items, non-operating pension expense and discontinued operations.
IP: 53.60 (-0.06)

Notable earnings before Tuesday's open
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:30PM CST

HSNI: 69.70 (+0.03), HCLP: 42.69 (-1.34), KORS: 68.70 (-0.45), DX: 8.49 (-0.01), HW: 13.14 (+0.06), MSI: 63.75 (-0.19), AER: 44.38 (+0.21), MFA: 8.25 (+0.02), GDP: 8.30 (-0.28), MWW: 4.48 (+0.10), EOG: 98.12 (-0.38), AYR: 20.34 (+0.04), LNCE: 29.96 (-0.44), EXH: 34.39 (-0.01), HEP: 33.99 (-0.47), ENBL: 23.35 (-0.21), NCT: 4.87 (+0.13), FE: 37.41 (+0.06), AFSI: 50.61 (+0.07), IP: 53.60 (-0.06), NNN: 38.30 (-0.63), BKW: 32.48 (+0.07), EXLP: 26.93 (-0.36), ARCC: 16.32 (-0.01), IRWD: 14.00 (+0.16), EXPD: 43.99 (-0.31), IMN: 2.98 (-0.06), ARCO: 6.68 (-0.14), CVS: 89.88 (+0.69), EL: 72.82 (-0.01), BLMN: 21.15 (-0.20), HMSY: 21.46 (-0.14), IFF: 99.91 (+0.62), BDX: 128.81 (+0.51), CLDT: 25.79 (+0.02), N: 109.18 (-0.56), AKS: 6.29 (-0.34), CIE: 10.22 (+0.03), ALLT: 10.49 (+0.10), CCG: 7.17 (+0.01), ETR: 82.99 (-0.30), IRC: 10.64 (-0.01), LINE: 23.32 (-0.40), LINC: 3.61 (+0.03), HCP: 43.40 (-0.07), HCN: 71.01 (-0.13), NGLS: 56.74 (-1.38), EMR: 64.50 (-0.61), HPT: 30.09 (-0.18), DISCA: 31.90 (-0.36), ICE: 220.93 (+1.60), DISH: 63.85 (+0.18), IPXL: 29.28 (+0.23), DWRE: 61.00 (+0.27), GLT: 26.74 (+0.22), CONE: 26.96 (-0.27), ATRO: 53.35 (-0.41), ARRY: 3.90 (+0.06), BABA: 114.87 (-4.28)

Will International Paper (IP) Disappoint on Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 4:20PM CST
International Paper Company (IP) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 4.
NSM: 27.75 (-0.45), IP: 53.60 (-0.06), L: 43.38 (-0.08), KMPR: 36.88 (-0.02)

Forget Geopolitics, Earnings Are What's Pushing the S&P Higher
at The Street - Mon Nov 03, 1:47PM CST
But did the 'Santa Claus rally' come too early? the "Fast Money" trading panel wondered.
CHRW: 71.68 (-0.49), HTZ: 22.35 (+0.34), BWP: 16.98 (-0.15), FB: 74.16 (-0.84), IP: 53.60 (-0.06), M: 59.00 (-0.26), WLT: 2.85 (-0.31), MAR: 77.19 (+0.63), INTC: 33.39 (+0.13), TLT: 118.40 (-0.25), GOOG: 549.55 (+2.06), CVD: 100.57 (-0.30), V: 249.19 (-1.02), SPY: 203.96 (-0.02), QQQ: 102.04 (+0.08), DIA: 175.91 (-0.04), LH: 100.33 (-0.65), GOOGL: 560.68 (+2.45), IWM: 117.17 (-0.12), TWTR: 38.89 (-0.70), AAPL: 108.81 (-0.02), MA: 84.32 (-0.53), NVS: 92.52 (-0.11), BABA: 114.87 (-4.28)

What to Expect When International Paper (IP) Reports Third-Quarter Earnings Tuesday
at The Street - Mon Nov 03, 1:13PM CST
International Paper (IP) is gaining ahead of reporting its third-quarter earnings report before the market opens on Tuesday .
IP: 53.60 (-0.06)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading